Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: A population-based study

Heart

Volumn 98, Issue 22, 2012, Pages 1667-1673

  Khoshnood, Babak ^a   Lelong, Nathalie ^a   Houyel, Lucile ^b   Thieulin, Anne Claire ^a   Jouannic, Jean Marie ^c   Magnier, Suzel ^d   Delezoide, Anne Lise ^d   Magny, Jean Francois ^e   Rambaud, Caroline ^f   Bonnet, Damien ^g   Goffinet, Francois ^a  

^a Maternité de Port Royal ^*  (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e Institut de Puericulture   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONGENITAL HEART DISEASE; DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; FETUS DEATH; FRANCE; HUMAN; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; NEWBORN MORTALITY; PERINATAL PERIOD; POPULATION RESEARCH; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; TIMING OF DIAGNOSIS;

CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; MALE; PARIS; POPULATION SURVEILLANCE; PREVALENCE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84868466125     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302543     Document Type: Article

References (29)

1. Dolk H, Loane M, Garne E; European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011;123:841-8.
2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-800.
3. Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth defectseAtlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep 2008;57:1-5.
4. van der Linde D, Konings EE, Slager MA, et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 2011;58:2241-7.
5. Blyth M, Howe D, Gnanapragasam J, et al. The hidden mortality of transposition of the great arteries and survival advantage provided by prenatal diagnosis. BJOG 2008;115:1096-100. (Pubitemid 352000368)
6. Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999;99:916-18. (Pubitemid 29094306)
7. Khoshnood B, De VC, Vodovar V, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation. Pediatrics 2005;115:95-101.
8. Centers for Disease Control and Prevention (CDC). Trends in infant mortality attributable to birth defectseUnited States, 1980-1995. MMWR Morb Mortal Wkly Rep 1998;47:773-8.
9. Centers for Disease Control and Prevention (CDC). Racial differences by gestational age in neonatal deaths attributable to congenital heart defectsdUnited States, 2003-2006. MMWR Morb Mortal Wkly Rep 2010;59:1208-11.
10. Blondel B, Eb M, Matet N, et al. [Neonatal mortality in France: usefulness of a neonatal death certificate] (In French). Arch Pediatr 2005;12:1448-55. (Pubitemid 41431509)
11. Hatton F, Bouvier-Colle MH, Blondel B, et al. [Trends in infant mortality in France: frequency and causes from 1950 to 1997] (In French). Arch Pediatr 2000;7:489-500. (Pubitemid 30305482)
12. Wernovsky G, Newburger J. Neurologic and developmental morbidity in children with complex congenital heart disease. J Pediatr 2003;142:6-8. (Pubitemid 36106379)
13. Wernovsky G, Shillingford AJ, Gaynor JW. Central nervous system outcomes in children with complex congenital heart disease. Curr Opin Cardiol 2005;20:94-8.
14. Meberg A, Otterstad JE, Froland G, et al. Outcome of congenital heart defectsea population-based study. Acta Paediatr 2000;89:1344-51.
15. Marek J, Tomek V, Skovranek J, et al. Prenatal ultrasound screening of congenital heart disease in an unselected national population: a 21-year experience. Heart 2011;97:124-30.
16. Franklin RC, Jacobs JP, Krogmann ON, et al. Nomenclature for congenital and paediatric cardiac disease: historical perspectives and The International Pediatric and Congenital Cardiac Code. Cardiol Young 2008;18(Suppl 2):70-80.
17. Strickland MJ, Riehle-Colarusso TJ, Jacobs JP, et al. The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young 2008;18(Suppl 2):92-100.
18. Jacobs JP, Mavroudis C, Jacobs ML, et al. Nomenclature and databases - the past, the present, and the future: a primer for the congenital heart surgeon. Pediatr Cardiol 2007;28:105-15. (Pubitemid 46733839)
19. Jacobs JP, Jacobs ML, Mavroudis C, et al. Nomenclature and databases for the surgical treatment of congenital cardiac diseaseean updated primer and an analysis of opportunities for improvement. Cardiol Young 2008;18(Suppl 2):38-62.
20. Houyel L, Khoshnood B, Anderson RH, et al. Population-based evaluation of a suggested anatomic and clinical classification of congenital heart defects based on the International Paediatric and Congenital Cardiac Code. Orphanet J Rare Dis 2011;6:64.
21. Jenkins KJ, Gauvreau K, Newburger JW, et al. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 2002;123:110-18.
22. Al-Radi OO, Harrell FE Jr, Caldarone CA, et al. Case complexity scores in congenital heart surgery: a comparative study of the Aristotle Basic Complexity score and the Risk Adjustment in Congenital Heart Surgery (RACHS-1) system. J Thorac Cardiovasc Surg 2007;133:865-75. (Pubitemid 46435924)
23. Jacobs ML, Jacobs JP, Jenkins KJ, et al. Stratification of complexity: the Risk Adjustment for Congenital Heart Surgery-1 method and the Aristotle Complexity Scoreepast, present, and future. Cardiol Young 2008;18(Suppl 2):163-8.
24. O'Brien SM, Clarke DR, Jacobs JP, et al. An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg 2009;138:1139-53.
25. Tararbit K, Houyel L, Bonnet D, et al. Risk of congenital heart defects associated with assisted reproductive technologies: a population-based evaluation. Eur Heart J 2011;32:500-8.
26. Botto LD, Lin AE, Riehle-Colarusso T, et al. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 2007;79:714-27. (Pubitemid 47584196)
27. Boyd PA, Devigan C, Khoshnood B, et al. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG 2008;115:689-86.
28. Khoshnood B, Greenlees R, Loane M, et al EUROCAT Working Group. Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol 2011;91(Suppl 1):S16-22.
29. Garne E, Khoshnood B, Loane M, et al EUROCAT Working Group. Termination of pregnancy for fetal anomaly after 23 weeks of gestation: a European register-based study. BJOG 2010;117:660-6.